Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study
- PMID: 26956880
- PMCID: PMC4782350
- DOI: 10.1186/s12879-016-1446-x
Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study
Abstract
Background: There are inconsistencies in the literature on reproductive and genital health determinants of human papillomavirus (HPV) infection, the primary cause of cervical cancer. We examined these factors in the Ludwig-McGill Cohort Study, a longitudinal, repeated-measurements investigation on the natural history of HPV infection.
Methods: We analyzed a cohort subset of 1867 women with one complete year of follow-up. We calculated odds ratios (OR) and 95% confidence intervals (CI) for reproductive and genital health characteristics from questionnaire and laboratory data in relation to 1-year period prevalence of HPV infection. Two outcomes were measured; the first based on phylogenetic grouping of HPV types based on tissue tropism and oncogenicity (Alphapapillomavirus Subgenus 1: species 1, 8, 10 and 13; Subgenus 2: species 5, 6, 7, 9, 11; Subgenus 3: species 3, 4 and 14) and the second based on transient or persistent HPV infections.
Results: Lifetime (Subgenus 3 OR = 2.00, CI: 1.23-3.24) and current (Subgenus 3 OR =2.00, CI: 1.15-3.47) condom use and use of contraceptive injections (Subgenus 1 OR = 1.96, CI: 1.22-3.16, Subgenus 2 OR = 1.34, CI: 1.00-1.79) were associated with increased risk of HPV infection. Intrauterine device use was protective (Subgenus 1 OR = 0.48, CI: 0.30-0.75, Subgenus 2 OR = 0.78, CI: 0.62-0.98). These factors were not associated with persistence of HPV infection. Tampon use, previous gynecologic infections and cervical inflammation were associated with an overall increased risk of HPV infection.
Conclusions: Cervical HPV infection was associated with reproductive and genital health factors. Further studies are necessary to confirm the low to moderate associations observed.
Figures

Similar articles
-
Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.Rev Panam Salud Publica. 1999 Oct;6(4):223-33. doi: 10.1590/s1020-49891999000900001. Rev Panam Salud Publica. 1999. PMID: 10572472
-
High-risk human papillomavirus infection and abnormal cervical cytology among Nepali and Bhutanese refugee women living in eastern Nepal.BMC Infect Dis. 2017 Jan 14;17(1):73. doi: 10.1186/s12879-017-2186-2. BMC Infect Dis. 2017. PMID: 28088173 Free PMC article.
-
Risk factors for cervical neoplasia in Denmark.APMIS Suppl. 1998;80:1-41. APMIS Suppl. 1998. PMID: 9693662
-
Human papillomavirus: the burden of infection.Obstet Gynecol Surv. 2006 Jun;61(6 Suppl 1):S3-14. doi: 10.1097/01.ogx.0000221010.82943.8c. Obstet Gynecol Surv. 2006. PMID: 16729902 Review.
-
The epidemiology of human papillomavirus infections.J Clin Virol. 2005 Mar;32 Suppl 1:S16-24. doi: 10.1016/j.jcv.2004.12.008. J Clin Virol. 2005. PMID: 15753008 Review.
Cited by
-
Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV): design and methods for a randomised controlled trial.BMJ Open. 2020 Mar 23;10(3):e035113. doi: 10.1136/bmjopen-2019-035113. BMJ Open. 2020. PMID: 32205376 Free PMC article.
-
Prevalence of Candida albicans in High-Risk Human Papillomavirus-Positive Women: A Study in Diyarbakır Province, Turkey.Can J Infect Dis Med Microbiol. 2023 Oct 10;2023:9945561. doi: 10.1155/2023/9945561. eCollection 2023. Can J Infect Dis Med Microbiol. 2023. PMID: 37854871 Free PMC article.
-
Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.J Med Microbiol. 2020 Jul;69(7):960-970. doi: 10.1099/jmm.0.001213. J Med Microbiol. 2020. PMID: 32510304 Free PMC article.
-
Efficacy and safety of a self-applied carrageenan-based gel to prevent human papillomavirus infection in sexually active young women (CATCH study): an exploratory phase IIB randomised, placebo-controlled trial.EClinicalMedicine. 2023 Jun 8;60:102038. doi: 10.1016/j.eclinm.2023.102038. eCollection 2023 Jun. EClinicalMedicine. 2023. PMID: 37396806 Free PMC article.
-
Co-infection of sexually transmitted pathogens and Human Papillomavirus in cervical samples of women of Brazil.BMC Infect Dis. 2017 Dec 15;17(1):769. doi: 10.1186/s12879-017-2835-5. BMC Infect Dis. 2017. PMID: 29246195 Free PMC article.
References
-
- Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. 2010.
-
- Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006;24(Suppl 3):S3/52–61. - PubMed
-
- Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24(Suppl 1):S1–15. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical